These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24305921)

  • 21. Routine central lymph node dissection with total thyroidectomy for papillary thyroid cancer potentially minimizes level VI recurrence.
    Hall CM; Snyder SK; Maldonado YM; Lairmore TC
    Surgery; 2016 Oct; 160(4):1049-1058. PubMed ID: 27521047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radio-guided selective compartment neck dissection improves staging in papillary thyroid carcinoma: a prospective study on 345 patients with a 3-year follow-up.
    Carcoforo P; Portinari M; Feggi L; Panareo S; De Troia A; Zatelli MC; Trasforini G; Degli Uberti E; Forini E; Feo CV
    Surgery; 2014 Jul; 156(1):147-57. PubMed ID: 24929764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lateral lymph node recurrence after total thyroidectomy and central neck dissection in patients with papillary thyroid cancer without clinical evidence of lateral neck metastasis.
    Lim YC; Liu L; Chang JW; Koo BS
    Oral Oncol; 2016 Nov; 62():109-113. PubMed ID: 27865362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrence factors and prevention of complications of pediatric differentiated thyroid cancer.
    Wang C; Chen X; Wei X; Chen F; Wang Y; Shen Z
    Asian J Surg; 2017 Jan; 40(1):55-60. PubMed ID: 27697309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identifying risk factors of recurrence for clinically node negative papillary thyroid carcinoma with pathologic N1a.
    Ryu YJ; Cho JS; Park MH; Yoon JH
    BMC Surg; 2019 Jul; 19(1):78. PubMed ID: 31277631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The number of positive lymph nodes in the central compartment has prognostic impact in papillary thyroid cancer.
    Rajeev P; Ahmed S; Ezzat TM; Sadler GP; Mihai R
    Langenbecks Arch Surg; 2013 Mar; 398(3):377-82. PubMed ID: 23274361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck.
    Lee CW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Ann Surg Oncol; 2015 Jan; 22(1):117-24. PubMed ID: 25034816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical features, treatment, and long-term outcome of papillary thyroid cancer in children and adolescents without radiation exposure.
    Enomoto Y; Enomoto K; Uchino S; Shibuya H; Watanabe S; Noguchi S
    World J Surg; 2012 Jun; 36(6):1241-6. PubMed ID: 22411092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of prophylactic modified radical neck dissection for patients with low-risk papillary thyroid carcinoma measuring 1.1-3.0 cm: first report of a trial at Kuma Hospital.
    Ito Y; Tsushima Y; Masuoka H; Yabuta T; Fukushima M; Inoue H; Tomoda C; Kihara M; Higashiyama T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
    Surg Today; 2011 Nov; 41(11):1486-91. PubMed ID: 21969150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
    Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
    Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Papillary thyroid cancer: controversies in the management of neck metastasis.
    Davidson HC; Park BJ; Johnson JT
    Laryngoscope; 2008 Dec; 118(12):2161-5. PubMed ID: 19029855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal value of lymph node ratio and metastatic lymph node size to predict risk of recurrence in pediatric thyroid cancer with lateral neck metastasis.
    Back K; Kim TH; Lee J; Kim JS; Choe JH; Oh YL; Cho A; Kim JH
    J Pediatr Surg; 2023 Mar; 58(3):568-573. PubMed ID: 35973863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of metastatic lymph node ratio on stimulated thyroglobulin levels in papillary thyroid carcinoma after prophylactic unilateral central neck dissection.
    Lang BH; Wong KP; Wan KY; Lo CY
    Ann Surg Oncol; 2012 Apr; 19(4):1257-63. PubMed ID: 21989667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The stratification of patient risk depending on the size and ratio of metastatic lymph nodes in papillary thyroid carcinoma.
    Hong YR; Lee SH; Lim DJ; Kim MH; Jung CK; Chae BJ; Song BJ; Bae JS
    World J Surg Oncol; 2017 Apr; 15(1):74. PubMed ID: 28376807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identifying risk factors of lateral lymph node recurrence in clinically node-negative papillary thyroid cancer.
    Ryu YJ; Kang SJ; Cho JS; Yoon JH; Park MH
    Medicine (Baltimore); 2018 Dec; 97(51):e13435. PubMed ID: 30572443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determining the extent of lateral neck dissection necessary to establish regional disease control and avoid reoperation after previous total thyroidectomy and radioactive iodine for papillary thyroid cancer.
    Wu G; Fraser S; Pai SI; Farrag TY; Ladenson PW; Tufano RP
    Head Neck; 2012 Oct; 34(10):1418-21. PubMed ID: 22052539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal extent of prophylactic central neck dissection for papillary thyroid carcinoma: Comparison of unilateral versus bilateral central neck dissection.
    Yoo HS; Shin MC; Ji YB; Song CM; Lee SH; Tae K
    Asian J Surg; 2018 Jul; 41(4):363-369. PubMed ID: 28454667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Not the number but the location of lymph nodes matters for recurrence rate and disease-free survival in patients with differentiated thyroid cancer.
    de Meer SG; Dauwan M; de Keizer B; Valk GD; Borel Rinkes IH; Vriens MR
    World J Surg; 2012 Jun; 36(6):1262-7. PubMed ID: 22270993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical response to radioactive iodine therapy for prophylactic central neck dissection is not superior to total thyroidectomy alone in cN0 patients with papillary thyroid cancer.
    Lin B; Qiang W; Wenqi Z; Tianyu Y; Lina Z; Bin J
    Nucl Med Commun; 2017 Dec; 38(12):1036-1040. PubMed ID: 28953211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.
    Zhao H; Huang T; Li H
    Surgery; 2019 Jul; 166(1):55-60. PubMed ID: 30876667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.